Migraine Disease Epidemiology Market Analysis and Forecasts to 2038 - ResearchAndMarkets.com

DUBLIN--()--The "Migraine Disease Coverage Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.

Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days. Prevalence of migraine is higher in urban areas and in women. Causes of migraine are incompletely understood, but genetics and lifestyle are both involved in migraine and progression of migraine severity. Common co-morbidities for migraine include psychiatric conditions such as anxiety and depression.

Market Snapshot

The prevalent population of this common condition is likely to remain stable over the forecast period.

Key Topics Covered:

EPIDEMIOLOGY: MIGRAINE

Overview

Disease Background

Methodology

Forecast

Bibliography

Appendix: Additional Sources

LIST OF FIGURES

Figure 1: Trends in total prevalent cases of migraine (including definite and probable migraine) in the US, Japan, and five major EU markets, by country, 2018-38

LIST OF TABLES

Table 1: Sources used for the epidemiological analysis of migraine in the US, Japan, and five major EU markets, by country

Table 2: Total prevalent cases of migraine (including definite and probable migraine) in the US, Japan, and five major EU markets, by country, 2018-38

For more information about this report visit https://www.researchandmarkets.com/r/usgj0m

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs, Analgesics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs, Analgesics